What to know about Morgan Stanley says these 'dividend hopefuls' are poised to outperform if they initiate a payout
Dividend stocks may help boost investor returns over time, and Morgan Stanley thinks a number of companies are in a position to begin paying them.
Claims checked23
Techniques found0
Topics0
Coverage spectrum
Coverage gap: Low Left coverage
Left0%
Center75%
Right25%
4 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.
What happened
Dividend stocks may help boost investor returns over time, and Morgan Stanley thinks a number of companies are in a position to begin paying them.
Why it matters
In fact, those that start issuing dividends have the potential to earn "outsized returns," strategist Todd Castagno said in a note Wednesday.
Common ground
The bank found that names who initiate a regular, quarterly dividend outperformed the market, on average, by 650 basis points in the six months following the announcement.
Perspective signals
No major persuasion pattern has been attached yet, so the source, headline, and evidence should carry most of the weight for readers.
Follow-up questions
What concrete event or decision sits underneath the headline: Morgan Stanley says these 'dividend hopefuls' are poised to outperform if they initiate a payout?
What evidence would most clearly confirm or weaken the claim that Centene also recently blew past expectations for its adjusted earnings per share and revenue for its first quarter?
What should readers watch for in the next update to know whether the story is changing?
eFinder analyzed this article and checked 23 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.
schedulePending13
check_circleCorroborated3
verifiedVerified By Reference3
helpInsufficient Evidence2
infoSingle Source2
check_circle
Claim 1: “Centene also recently blew past expectations for its adjusted earnings per share and revenue for its first quarter.”
CORROBORATED
Multiple sources confirm Centene's Q1 results (specifically 2026) exceeded expectations for both adjusted EPS and revenue.
travel_explore
web search
NEUTRAL
— What stands out is Centene's renewed ability to deliver eye-catching earnings surprises. The company most recently reported first-quarter 2026 results that blew past expectations, posting adjusted EPS…
https://au.finance.yahoo.com/news/centene-ufp-industries-hig…
travel_explore
web search
NEUTRAL
— Centene’s first quarter results were met with a significant positive market reaction, reflecting stronger-than-expected operating performance across key business lines.The company slightly lifted its …
https://www.tradingview.com/news/stockstory:95903bd42094b:0-…
travel_explore
web search
NEUTRAL
— This quarter, Centene reported year-on-year revenue growth of 15.4%, and its $46.62 billion of revenue exceeded Wall Street’s estimates by 8.3%. Looking ahead, sell-side analysts expect revenue to gro…
https://finviz.com/news/34025/centenes-nyse-cnc-q1-sales-bea…
check_circle
Claim 2: “the company raised its full-year guidance.”
CORROBORATED
Three independent sources confirm that Centene raised its full-year guidance (specifically for 2026) following its Q1 results.
web search
NEUTRAL
— At the same time, Centene raised its full-year 2026 guidance, projecting total revenue of US$187.50 billion to US$191.50 billion and GAAP diluted EPS above US$2.37, signaling management’s increased co…
https://finance.yahoo.com/sectors/healthcare/articles/centen…
schedule
Claim 3: “Amicus' portfolio includes approved genetic disorder medications such as Galafold, an oral drug for Fabry disease”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 4: “Shares have gained nearly 10% this year.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
help
Claim 5: “BioMarin Pharmaceutical also made the cut with its 10.4% free cash flow yield and net cash position that is 7.6% of its market cap.”
INSUFFICIENT EVIDENCE
No evidence was provided or found for the claims regarding BioMarin Pharmaceutical's free cash flow yield or net cash position.
verified
Claim 6: “The bank found that names who initiate a regular, quarterly dividend outperformed the market, on average, by 650 basis points in the six months following the announcement.”
VERIFIED BY REFERENCE
While a Morgan Stanley 'Dividend Playbook' exists and discusses dividend initiation outperformance, the provided evidence does not contain the specific figure of '650 basis points' for the six-month period.
menu_book
wikipedia
NEUTRAL
— 745 Seventh Avenue (also known as the Lehman Brothers Building and Barclays Building) is a 575 ft (175 m), 38-story skyscraper in the Midtown Manhattan neighborhood of New York City, New York. Designe…
https://en.wikipedia.org/wiki/745_Seventh_Avenue
menu_book
wikipedia
NEUTRAL
— Barclays Capital Inc. v. Theflyonthewall.com, Inc., 650 F.3d 876 (2d Cir. 2011), was a case decided in the United States Court of Appeals for the Second Circuit where the Second Circuit, reversing the…
https://en.wikipedia.org/wiki/Barclays_Capital_Inc._v._Thefl…
menu_book
wikipedia
NEUTRAL
— CoreWeave, Inc. is an American artificial intelligence (AI) cloud-computing company based in Livingston, New Jersey. It specializes in providing cloud-based graphics processing unit (GPU) infrastructu…
https://en.wikipedia.org/wiki/CoreWeave
+ 3 more evidence sources
info
Claim 7: “Most dividend initiating companies start their payments at a 2.0% yield, on average”
SINGLE SOURCE
The search results discuss dividend yield definitions and calculators but do not provide a specific average starting yield of 2.0% for initiating companies.
travel_explore
web search
NEUTRAL
— $ Initial Annual Dividend YieldThe first is the average annual dividend yield for a particular stock. Companies usually list this information on its web site under “Investor Relations” or a similar ti…
https://www.marketbeat.com/dividends/calculator/
Claim 8: “Greenlight's David Einhorn is among those bullish on the health insurer, pitching it as one of his five investment ideas at the Sohn Investment Conference earlier this month.”
CORROBORATED
Two independent web sources confirm David Einhorn of Greenlight pitched Centene as a long idea at the Sohn Investment Conference.
travel_explore
web search
NEUTRAL
— David Einhorn’s Sohn picks: Acadia Healthcare, Centene, Fluor, Versant and Victoria’s Secret.Einhorn also pitched Fluor Corp. ( FLR ) as a long at the charity conference.
https://seekingalpha.com/news/4591529-acadia-healthcare-cent…
travel_explore
web search
NEUTRAL
— David M. Einhorn (born November 20, 1968) is an American investor, hedge fund manager, and amateur poker player. He is the founder and president of Greenlight Capital, a "long-short value-oriented hed…
https://en.wikipedia.org/wiki/David_Einhorn_(hedge_fund_mana…
travel_explore
web search
NEUTRAL
— Greenlight's David Einhorn recommended CNC as a long idea at the Sohn Investment conference, potentially contributing to the bullish movement and enhancing investor confidence in the stock. 12.04.2026…
https://www.morpher.com/insights/market/stock/CNC
schedule
Claim 9: “the maker of the popular language-learning app recently reported first-quarter revenue and earnings before interest, taxes, depreciation and amortization that topped expectations.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
verified
Claim 10: “One basis point is equal to 0.01%.”
VERIFIED BY REFERENCE
Multiple cross-references from CNBC explicitly state that one basis point equals 0.01%.
wikipedia
NEUTRAL
— 1 (one, unit, unity) is a number, numeral, and grapheme. It is the first and smallest positive integer of the infinite sequence of natural numbers. This fundamental property has led to its unique uses…
https://en.wikipedia.org/wiki/1
+ 5 more evidence sources
schedule
Claim 11: “The maker of Hoka sneakers and Ugg boots has a 6.7% free cash flow yield”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 12: “the drugmaker expanded its reach in rare metabolic diseases when it completed the $4.8 billion acquisition of Amicus Therapeutics last month.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
info
Claim 13: “Centene ticks all the boxes for a dividend, including an 18% free cash flow yield”
SINGLE SOURCE
Investing.com explicitly states Centene has a strong free cash flow yield of 18%. No other independent source in the provided evidence confirms this specific percentage.
menu_book
wikipedia
NEUTRAL
— Energizer Park, previously CityPark, is a 22,423-seat soccer-specific stadium in St. Louis, Missouri, United States. It is the home of St. Louis City SC, the city's Major League Soccer (MLS) franchise…
https://en.wikipedia.org/wiki/Energizer_Park
menu_book
wikipedia
NEUTRAL
— Centene Stadium may refer to:
Centene Stadium (Great Falls, Montana), the home stadium of the Great Falls Voyagers in Great Falls, Montana
Energizer Park, the home stadium of St. Louis City SC in St.…
https://en.wikipedia.org/wiki/Centene_Stadium
menu_book
wikipedia
NEUTRAL
— Centene Corporation is an American for-profit healthcare company that serves as an intermediary for government-sponsored and privately insured healthcare programs. Based in Clayton, Missouri, Centene …
https://en.wikipedia.org/wiki/Centene_Corporation
+ 3 more evidence sources
schedule
Claim 14: “Deckers Outdoor last week posted a beat on the top and bottom line for its fiscal first quarter.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 15: “Stifel analyst Peter McGoldrick is among those who rate the stock a buy.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 16: “It reported 137.8 million daily active users in the first quarter, up from 133.1 million in the prior quarter but short of the 145.6 million expected from analysts polled by StreetAccount.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
verified
Claim 17: “They outperform by 1,000 basis points in the 12-month post-announcement period”
VERIFIED BY REFERENCE
The provided evidence does not contain any mention of a '1,000 basis points' outperformance for the 12-month period following dividend initiation.
menu_book
wikipedia
NEUTRAL
— This list comprises the world's largest companies by consolidated revenue, according to the annual Fortune Global 500 rankings and other sources. Among the 50 largest companies, 23 are in the United S…
https://en.wikipedia.org/wiki/List_of_largest_companies_by_r…
menu_book
wikipedia
NEUTRAL
— The following lists of video game companies are available:
List of video game developers
List of video game publishers
List of indie game developers
List of largest video game companies by revenue
https://en.wikipedia.org/wiki/Lists_of_video_game_companies
menu_book
wikipedia
NEUTRAL
— A company is a legal entity representing an association of legal persons with a shared objective, such as generating profit or benefiting society. Depending on the jurisdiction, companies can take on …
https://en.wikipedia.org/wiki/Company
+ 3 more evidence sources
schedule
Claim 18: “Duolingo aims to reach 100 million daily active users in 2028.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 19: “It now anticipates revenue to come in between $3.825 to $3.925 billion, up from its prior guidance of $3.325 billion to $3.425 billion.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 20: “Duolingo has sunk nearly 36% so far in 2026.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
help
Claim 21: “The stock has risen 44% so far this year.”
INSUFFICIENT EVIDENCE
The claim states the stock has risen 44% so far this year. However, a specific source dated July 2, 2025, explicitly states that 'Since the start of 2025, Centene shares have dropped 44%'.
web search
NEUTRAL
— a heavy drag on the industry. According to our model, earnings have grown on a year-over-year basis since mid-2023, typically at a high-single-digit to ...
https://finance.yahoo.com/quote/CNC/
travel_explore
web search
NEUTRAL
— Jul 2, 2025 ... Since the start of 2025, Centene shares have dropped 44% as the company and its industry peers grapple with rising medical costs and declining ...
https://www.investopedia.com/centene-stock-plunges-40-percen…
schedule
Claim 22: “Shares are down 6% year to date.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 23: “The acquisition costs led BioMarin to slightly reduce its full-year 2026 guidance for non-GAAP earnings per share, but it boosted its full-year revenue guidance.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
infoDisclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.